Lumen enlargement during coronary stenting results from vessel expansion and axial redistribution of atheromatous plaque along the stented segment and proximal and distal reference segments. Plaque burden predicts stenosis at the stent edge. The aim of this study was to investigate the fate of shifted plaque with special reference to whether or not plaque shift (PSh) correlates with late lumen reduction. This is a prospective study conducted on 54 consecutive patients who underwent bare metal stenting. In all stent edges (108 edges), PSh volume was measured as postintervention plaque-media volume (PMV) minus preintervention PMV. Changes in lumen volume (∆LV), vessel volume (∆VV), and PMV (∆PMV) were measured by serial intravascular ultrasound (IVUS) examination. After stenting, PSh was detected in 81.5% of proximal edges versus 72.2% of distal edges (P = 0.36). It correlated significantly with ∆VV (r = 0.34, P = 0.002), and inversely with ∆LV (r = 0.32, P = 0.003). However, at 6-month follow-up, it did not correlate with ∆LV (r = −0.03, P = 0.8), ∆VV (r = 0.1, P = 0.6), or ∆PMV (r = 0.1, P = 0.4). Furthermore, ∆LV correlated more strongly with ∆VV (r = 0.62, P < 0.00001) than with ∆PMV (r = − 0.39, P = 0.001). By multivariate analysis, PSh area was an independent predictor of the postintervention change in lumen area (partial eta squared 0.21, P = 0.01), but not the follow-up change. Two patients (3.7%) developed proximal edge stenosis with no evident PSh after stenting. Thus, axial redistribution of atheromatous plaque into the reference segments was frequently encountered after stenting. Although PSh correlated with the immediate reduction in stent edge lumen volume, it did not correlate with the late lumen reduction. (Int Heart J 2006; 47: 159-171) 
formed for optimizing stent deployment. Lumen enlargement at the lesion site has been studied by using either planar or volumetric IVUS analysis. Longitudinal atheromatous plaque redistribution into the reference segments (10 mm from the dilated segment in proximal and distal directions) has been confirmed during balloon angioplasty 1) and coronary stenting. 2, 3) Together with vessel expansion, plaque compression and embolization has also been recognized during stent deployment. 4) Furthermore, distal embolization observed after vein graft stenting 5) may have plaque debris. Direct and predilatation coronary stenting have similar mechanisms of lumen enlargement. 6, 7) Nevertheless, the immediate and long-term effects of plaque shift on the stent edge have not been fully investigated. The occurrence of plaque shift after stent deployment may interfere greatly with coronary blood flow especially in small to medium sized vessels or plaqueloaded reference segments so that it is necessary for the operator to perform further intervention to restore coronary flow. However, when plaque shift results in a partially limiting lumen narrowing, there is controversy over treating as opposed to nonintervention. The aim of this study was to investigate the fate of shifted plaque with special reference to whether or not plaque shift correlates with late lumen reduction.
METHODS

Study population:
Patients with stable and unstable angina pectoris and myocardial infarction due to de novo native coronary artery disease were included in this study. All patients who underwent IVUS-guided percutaneous coronary intervention without prior atherectomy were scheduled to follow-up coronary angiography with IVUS examination after 6 months. Lesions with chronic total occlusion, presence of major side branches at the stent edges, poststent balloon dilatation at the stent edge, angiographic evidence of thrombus within the target lesion, or poor IVUS image acquisition were excluded. To test the association with the follow-up change in stent edge lumen area, a calculated sample size of 105 stent edges (53 patients) would achieve 80% power to detect an R-squared of 0.05 attributed to plaque shift with a significance level of 0.05. The variables tested were adjusted for an additional 10 independent variables with an R-squared of 0.3. All patients enrolled in the study gave written informed consent for the implantation procedures and the follow-up investigation. Coronary-stent procedures: On the basis of diagnostic coronary angiography, a patient underwent coronary intervention if one or more major coronary arteries had a stenosis of at least 70% and were suitable for revascularization. Since drugeluting stents were not available at the beginning of the study, only bare metal stents were used. The decision concerning direct (9 patients) and predilatation (45
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No.2 patients) stenting was left to the discretion of the operator. Heparin was administered intravenously to maintain an activated clotting time > 300 seconds. Coronary stenting was guided by IVUS examination before and after stenting. If incomplete stent expansion detected by IVUS or residual angiographic stenosis > 20% on visual assessment were identified, further balloon dilatation was performed to achieve optimal stenting results. The patients received a combination of aspirin 100 mg daily and ticlopidine 200 mg daily for 2-4 weeks. All patients were seen regularly in the outpatient department and were scheduled for a 6-month follow-up angiography using IVUS examination or earlier if symptoms or stress echocardiography suggested restenosis. The follow-up study was performed in all patients at a mean of 213 ± 92 days after stenting. Quantitative coronary angiographic (QCA) analysis: Preintervention, postintervention, and follow-up cineangiograms were analyzed using a quantitative coronary angiographic automated edge detection algorithm (QCA-CMSR, version 4, MEDIS). The outer diameter of the contrast-filled catheter was used for calibration. Reference diameter, minimal lumen diameter, and percentage diameter stenosis before and after intervention and at follow-up were measured from multiple projections, and the results from the narrowest view were recorded. Analysis was conducted on stent site and proximal and distal edges outside the stent. Restenosis was defined as a percentage diameter stenosis ≥ 50%. IVUS procedure and analysis: Every IVUS examination was performed using a 2.5F catheter operating on a frequency of 40 MHz (Boston Scientific, SCIMED). After administration of intracoronary nitrates, the transducer was positioned in the distal vessel, at least 10 mm distal to the lesion, and withdrawn at a rate of 0.5 mm per second with the use of a motor drive to the aorto-ostial junction. Continuous IVUS studies were recorded on S-VHS video tapes for off-line analysis. Area and volumetric measurements were performed with a commercially available program for computerized analysis (NetraIVUS, version 2.04, ScImage, Inc., Los Altos, CA).
On a computer screen, measurements were conducted on the distal stent edge (5 mm from last stent strut), the stent site, and the proximal stent edge (5 mm from first stent strut). The 3 sites were identified in preintervention, postintervention, and follow-up IVUS studies using one or more reproducible axial landmarks (such as large proximal or distal side branches, calcium deposits, or stent struts) and a known pullback speed. Manual planimetry was used to measure external elastic membrane area (vessel area, VA) and lumen area (LA) in all frames. The computer program calculated and saved the measurements for each section (0.1 mm in thickness). Shifted plaque volume was calculated as postintervention stent edge plaque-media volume (PMV) minus preintervention stent edge PMV. Serial volumetric comparisons were conducted for the lesion site (stent plus stent edges) and the stent edge site. Segmental analysis was conducted on every 1 mm segment (5 segments). The narrowest lumen cross sectional area was identified at follow-up IVUS examination (minimal lumen cross sectional area) and compared with the corresponding slices in the preintervention and postintervention IVUS studies. Measurements were performed in accordance with the standards of the American College of Cardiology and the European Society of Cardiology. ). The intraclass correlation coefficient for repeated measurement of the LA was 0.97, of the VA was 0.99, and of the PMA area was 0.98. Statistical analysis: All statistical tests were performed using SPSS package (versions 9 and 13, SPSS, Inc., Chicago, Illinois) except the sample size calculation, which was calculated by NCSS/PASS program (Kaysville, Utah). Categorical variables are presented as frequencies. Continuous variables are reported as mean ± SD. Categorical variables were compared with the chi-square test or Fisher's exact test. For the comparisons of continuous variables a two-tailed Student t-test or Mann-Whitney U test was used. Repeated measurements for the same variable were compared using the repeated measures tool of the general linear model analysis. When the measurements of the 5 segments of the stent edge were compared, overall probability values were derived from ANOVA with post hoc comparisons using the Bonferroni correction. Correlations between variables are described with the use of Pearson correlation coefficients, and linear regression analyses were used to obtain partial correlation coefficients adjusted for covariates. Linear regression analyses were performed for adjusted, to vessel size, and unadjusted models. Univariate variables with P < 0.2 were entered into the multivariate tool of the general linear model to obtain the predictors of ∆LA data (treated vessel, lesion class, stent length, diameter, type, deployment pressure, preintervention minimal lumen diameter, percentage diameter stenosis, and postintervention percentage diameter stenosis), and IVUS data (preintervention and postintervention measurements). All statistical tests were two-sided. A P value < 0.05 was considered statistically significant. and angiographic data are shown in Table I . The majority of the patients presented with unstable angina due to de novo coronary atherosclerotic lesions in the left anterior descending artery. Stents were deployed in all patients to cover the whole lesion site (stent length/lesion length, 1.8 ± 1.1) using high balloon inflation pressure. At follow-up, 9 patients (17.7%) developed lesion restenosis, of which 2 (3.7%) had proximal stent edge stenosis that was focal (< 10 mm) in one patient and diffuse (> 10 mm) in the other patient.
RESULTS
This study was conducted from
10)
Changes at the stent edges: Table II shows the changes at the stent edges measured by IVUS. Immediately after stenting, shifted plaque from the stent site to the stent edges resulted in a significant increase in PMV in proximal and distal edges, while lesion (stent plus stent edges) PMV remained statistically unchanged from the preintervention measurement (Table III) . The increase in ∆PMV was comparable in proximal and distal edges, while ∆VV was significantly higher in the distal edge than in the proximal edge (P = 0.001). Consequently, ∆LV was significantly increased at the distal edge compared to the proximal edge (P < 0.001). The changes in ∆VV and ∆LV were more marked in the first 2 segments of the distal edge (close to the stent) than the rest of the segments (Table IV) . Nevertheless, both edges had comparable measurements of ∆LV, ∆VV, and ∆PMV at follow-up study. Furthermore, no statistically significant differences could be detected between lesions with and without predilatation, with or without postdilation. Of note, follow-up ∆LV correlated more ∆PMV (mm strongly with ∆VV (r = 0.62, P < 0.00001) than with ∆PMV (r = −0.39, P = 0.001). Effects of plaque shift on stent edges: Plaque shift was detected in 81.5% of the proximal edges and in 72.2% of the distal edges (P = 0.36). Although the proximal edge had a higher mean shifted plaque volume than the distal edge, the difference was not statistically significant (P = 0.095). Furthermore, the 5 segments of each stent edge received comparable volumes of the shifted plaque. Figure 1 shows the correlations between shifted plaque area and postintervention and follow-up ∆LA. The shifted plaque volume correlated significantly with postintervention ∆LV (r = −0.32, P = 0.003) and ∆VV (r = 0.34, P = 0.002), but not with follow-up ∆LV (r = −0.03, P = 0.8), ∆VV (r = 0.1, P = 0.6), and ∆PMV (r = 0.1, P = 0.4). In addition, plaque shift volume and plaque shift area did not correlate significantly with angiographic follow-up minimal lumen diameter, percentage diameter stenosis, or the changes in these parameters. Compared to edges without plaque shift (postintervention PMV ≤ preintervention PMV), edges with plaque shift had comparable postintervention and follow-up angiographic minimal lumen diameters, percentage diameter stenosis, LV, VV, and PMV (Table V) (Figure 2) . It was predominantly due to negative vessel remodeling.
Among the clinical, catheter, and IVUS data, the preintervention stent edge VV was selected as the independent predictor of the shifted plaque area at the 
DISCUSSION
The principal finding of this prospective study is that redistributed atheromatous plaque into the reference segments during high-pressure coronary stenting has a role in immediate but not late stent edge lumen reduction. The accumulation of shifted plaque at the stent edge can reduce the vessel lumen immediately after coronary stenting by a simple mechanical effect, while longterm vascular changes at the stent edge are responsible for late vascular lumen changes, which are not associated with plaque shift. It is unlikely that the failure to detect a significant correlation between the follow-up change in LV and the shifted plaque volume was due to inadequate sample size as recalculated sample size gave an 81% power. Postintervention changes: Ahmad, et al 4) reported plaque compression and embolization during coronary stenting. Therefore, shifted plaque volume was not calculated from the stent site but from the stent edge site as the postintervention PMV minus the preintervention PMV. The lesion preintervention PMV did not change significantly after coronary stenting so that significant plaque compression or embolization was not encountered in our study and performing measurements at more than a 5 mm distance from the stent site was not necessary. In our group of patients, vessel expansion and plaque redistribution into the reference segments were responsible for lesion lumen enlargement after coronary stenting. Whether plaque redistribution along the lesion site results in a significant increase in the stent edge PMV 2, 4, 6) or not, 3) it contributes to lesion lumen enlargement. The incidence of plaque shift was high with no statistically significant difference between the proximal and distal edges. Plaque shift was associated with stent edge lumen reduction in the proximal edge. Lumen gain was marked in the first 2 mm of the distal stent edge due to vessel wall stretch, however, a neighboring stent was responsible for this vessel stretch. The natural tapering of the coronary vessel from the proximal to the distal edges might exaggerate the effect of vessel stretch at the distal edge. Moreover, balloon protrusion outside the stent 11) may have an additional effect, especially at the distal edge. However, recent studies reported both lumen loss 4, 6) and lumen gain 7, 12) after coronary stenting. Follow-up changes: Unlike the contribution of plaque shift at the postintervention level, it did not correlate significantly with either follow-up ∆PMV or ∆VV and consequently it did not correlate significantly with ∆LV. Moreover, regression analyses were performed using measurements at follow-up minimal lumen cross sectional area to maximize the reduction in LA. Neither follow-up change in IVUS measurements of VA, PMA, and LA nor follow-up change in angiographic minimal lumen diameter and percentage diameter stenosis correlated with shifted plaque area, even in the adjusted model. Since there was no significant reduction of follow-up PMV from the postintervention measurement, geometric redistribution of shifted plaque could be excluded. Therefore, the results of the present study do not support the possible role of accumulation of atheromatous plaque at the stent edge in triggering further atherosclerotic processes. The plausible stimulus of late lumen reduction at the stent edge could be vessel trauma during coronary intervention. Vessel injury has been established as an important factor of late lumen loss after coronary intervention in animal [13] [14] [15] and in human 16) studies. Vessel response to balloon injury may resemble a wound healing process.
17) The use of a long stent-to-lesion ratio and direct stenting technique in our study might reduce vessel injury and consequently the incidence of stenosis at the stent edge was 3.7%. 18) Conflicting results were obtained from recent studies reporting the mechanisms of lumen reduction at the stent edge. Hoffmann, et al 19) found that the plaque burden of the reference segment was an independent predictor of stent edge stenosis. Other studies reported that a combination of intimal proliferation and negative remodeling was responsible for lumen reduction after bare metal stenting, [20] [21] [22] whereas edge stenosis after Paclitaxel-eluting stents and brachytherapy was due primarily to intimal proliferation. [22] [23] [24] Nevertheless, similar correlation between vessel remodeling and change in stent edge lumen was reported in the study of Mudra, et al. 25) Vessel remodeling has been established as an important factor that controls late lumen outcomes following coronary interventions 14, [26] [27] [28] [29] [30] as shown in the present study. This study may have a clinical benefit. It provides insight into the immediate and long-term effects of plaque shift on the stent edges following high-pressure stent deployment. The incidence of plaque shift detected by IVUS is high. It contributes significantly to immediate lumen reduction at the stent edge but not to late reduction. The results of this study do not support aggressive intervention with plaque shift at the stent edge to provide better long-term results. Study limitations: Since we encountered stenosis at 2 out of 108 edges, we could not make a comparison between edges with and without stenosis. Drug-eluting stents were not available at the start of the study so a comparison between bare metal stents and drug-eluting stent could not be performed. Patients who under-went coronary intervention using a cutting balloon and atherectomy devices were not included in the study.
